Da Silva Jorge Santos, Chief Executive Officer at MoonLake Immunotherapeutics (MLTX), sold 128,355 shares at $55.89 ($7.1M) on 2024-02-29, disclosed to the SEC on 2024-02-29.
Scheduled sale ($7.1M) by Chief Executive Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $55.00 | 62,810 | $3.5M | 48.9% |
| 2 | $55.00 | 56,065 | $3.1M | 43.6% |
| 3 | $55.89 | 4,740 | $265K | 3.7% |
| 4 | $55.89 | 4,740 | $265K | 3.7% |
| Total | $55.07 avg | 128,355 | $7.1M | 100% |
| Filing → |
| MLTX | SELL | 2026-04-14 | $2.8M | — | Filing → |
| MLTX | SELL | 2025-12-10 | $3.0M | — | Filing → |
| MLTX | SELL | 2024-02-23 | $124K | — | Filing → |